Georges Gemayel's Net Worth
$2.16 Million
Who is Georges Gemayel?
Georges Gemayel has an estimated net worth of $2.16 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Altus Pharmaceuticals Inc., SUPERNUS PHARMACEUTICALS, INC., Disc Medicine, Inc., Dimension Therapeutics, Inc., NPS PHARMACEUTICALS INC, Raptor Pharmaceutical Corp, ADOLOR CORP, and MOMENTA PHARMACEUTICALS INC.
SEC CIK
Georges Gemayel's CIK is 0001256088
Past Insider Trading and Trends
2011 was Georges Gemayel's most active year for acquiring shares with 9 total transactions. Georges Gemayel's most active month to acquire stocks was the month of April. 2020 was Georges Gemayel's most active year for disposing of shares, totalling 10 transactions. Georges Gemayel's most active month to dispose stocks was the month of September. 2007 saw Georges Gemayel paying a total of $1,839,585.30 for 121,096 shares, this is the most they've acquired in one year. In 2007 Georges Gemayel cashed out on 77,277 shares for a total of $2,850,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENZYME CORP No price found
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$61.20 | -$1,110,375.00 | 9.04K |
Oct 30
| |||
Form 4
| +34.37% | 2.28K |
$43.90 | $99,960.30 | 8.9K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4/A
| +59.64% | 3K |
$56.47 | $169,410.00 | 8.03K |
May 11
| |||
Form 4
| +28.36% | 2.28K |
$43.90 | $99,960.30 | 10.31K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +59.64% | 3K |
$56.47 | $169,410.00 | 8.03K |
May 11
| |||
Form 4
| +68.98% | 2.28K |
$56.26 | -$82,893.70 | 5.58K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +271.07% | 2.28K |
$55.34 | -$352,789.70 | 3.12K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Altus Pharmaceuticals Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SUPERNUS PHARMACEUTICALS, INC. (SUPN) Snapshot price: $33.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$24.04 | -$357,599.08 | 13.31K |
Nov 7
| |||
Form 4
| -22.59% | -3.89K |
$21.40 | -$320,448.38 | 13.31K |
Sep 13
| |||
Form 4
| +29.19% | 3.89K |
—
|
—
| 17.2K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +41.15% | 3.88K |
—
|
—
| 13.31K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +81.02% | 4.22K |
—
|
—
| 9.43K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
∞
| 5.21K |
$23.99 | $125,011.89 | 5.21K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Disc Medicine, Inc. (IRON) Snapshot price: $50.35
Executive Chair the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Dimension Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |